Related Experiment Video
Updated: Sep 17, 2025

13:34
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.3K
Adaptive dynamic ϵ-simulated annealing algorithm for tumor immunotherapy
1Department of Gynaecology, The People's Hospital of Liaoning Province, Shenyang, China.
Frontiers in Immunology
|July 3, 2025
Summary
This study introduces an Adaptive Dynamic ϵ-Simulated Annealing (ADϵSA) algorithm for optimizing personalized cancer treatments. The novel approach successfully reduced simulated tumor burden by over 66% while respecting biological constraints.
Area of Science:
- Computational oncology
- Mathematical modeling
- Bioinformatics
Background:
- Personalized cancer therapy necessitates precise scheduling of multiple agents.
- Optimizing treatment regimens is complex due to nonlinear tumor-immune dynamics and feasibility constraints.
Purpose of the Study:
- To develop an intelligent optimization approach for complex cancer treatment models.
- To address challenges in scheduling therapeutic agents under biological constraints.
Main Methods:
- An Adaptive Dynamic ϵ-Simulated Annealing (ADϵSA) algorithm was developed.
- The algorithm integrates multi-population search, dynamic ϵ-constraint control, and boundary-aware mutation.
- ADϵSA was applied to an improved tumor immunotherapy model (ITIT) using ordinary differential equations (ODEs).
Main Results:
- ADϵSA demonstrated strong global search capability, fast convergence, and solution stability on benchmark functions.
- The algorithm identified optimal drug schedules for the ITIT model, reducing simulated tumor burden from ~1500 to below 500 cells.
- Treatment remained within physiologically acceptable limits.
Conclusions:
- ADϵSA offers advantages over traditional methods like PSO and GA for dynamic, constraint-rich ODE systems.
- This work highlights the potential of biologically informed optimization in personalized oncology.
- The study provides a computational foundation for future closed-loop, patient-specific cancer treatment strategies.
Related Concept Videos
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

